|
1) 犬山シンポジウム記録刊行会. 劇症肝炎の診断基準. 第12回犬山シンポジウム. 東京: 中外医学社; 1982. p. 110
|
|
|
|
|
2) Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology. 2005; 41: 1179-97
|
|
|
|
|
3) 難治性肝疾患調査研究班 劇症肝炎分科会(鹿児島大学 坪内博仁教授). 劇症肝炎全国調査集計. 2005
|
|
|
|
|
|
4) Yazaki Y, et al. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J Gen Virol. 2003; 84: 2351-7
|
|
|
|
|
|
5) Mendel I, et al. Fulminant hepatitis in neonates with human herpesvirus 6 infection. Pediatr Infect Dis J. 1995; 14: 993-7
|
|
|
|
|
|
6) 永木正仁. 肝炎劇症化のメカニズム. In: 医学のあゆみ 消化器疾患 state of arts II. 肝・胆・膵. 東京: 医歯薬出版; 2006. p. 112-6
|
|
|
|
|
|
7) Sugauchi F, et al. Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan. Hepatol Res. 2006; 36: 107-14
|
|
|
|
|
8) 鈴木一幸, 他. 厚生省特定疾患対策研究事業｢難治性の肝疾患に関する研究｣班 平成13年度研究報告書. 2002; p. 87
|
|
|
|
|
|
9) 藤原研司, 他. 厚生労働省特定疾患対策研究事業｢難治性の肝疾患に関する研究｣班 平成16年度研究報告書. 2005. p. 93
|
|
|
|
|
|
10) Kotoh K, et al. Arterial steroid injection therapy can inhibit the progression of severe acute hepatic failure toward fulminant liver failure. World J Gastroenterol. 2006; 12: 6678-82
|
|
|
|
|
|
11) 日本肝移植研究会. 肝移植症例登録報告. 移植. 2006; 41: 599-608
|
|
|
|
|
|
12) 杉原潤一, 内藤智雄, 石木佳英, 他. わが国における劇症肝炎の予後予測と肝移植の適応に関する多施設研究. 肝臓. 2001; 42: 543-57
|
|
|
|
|
|
13) O'Grady JG, et al. Outcome of orthotopic liver transplantation in the aetiological and clinical variants of acute liver failure. Q J Med. 1988; 68: 817-24
|
|
|
|
|
|
14) Yantorno SE, et al. MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl. 2007; 13: 822-8
|
|
|
|
|
|
15) Chen SC, et al. Treatment of severe liver failure with a bioartificial liver. Ann NY Acad Sci. 1997; 831: 350-60
|
|
|
|
|
|
16) Naiki T, et al. Functional activity of human hepatoma cells transfected with adenovirus-mediated hepatocyte nuclear factor (HNF)-4 gene. Cell Transplant. 2004; 13: 393-403
|
|
|
|
|
|
17) Terai S, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells. 2006; 24: 2292-8
|
|
|
|
|